Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-28

https://bjgpopen.org/content/8/3/BJGPO.2024.0024

The 2024 studies on FebriDx indicate high user-friendliness, with clinicians noting that reading results is "dead easy" and comparing it to COVID-19 lateral flow tests. Despite positive feedback, users reported technical hurdles, including difficulty transferring blood into the test tube, challenges interpreting faint lines, and time constraints within 10-minute consultations. For more details, visit BJGP Open.

Mostly good, not perfect, ongoing engineering over the evolution of a new technology. Pretty normal.